543595 — EP Biocomposites Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹158.06m
- IN₹186.20m
- IN₹120.06m
Annual cashflow statement for EP Biocomposites, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 11.7 | 8.14 | 15.7 | 14.2 | 19.4 |
| Depreciation | |||||
| Non-Cash Items | 2.93 | 0.58 | -0.735 | 3.44 | 3.97 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -58.2 | -17.7 | -28.4 | -23.6 | -4.46 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -42.9 | -7.94 | -12.4 | -4.9 | 19.9 |
| Capital Expenditures | -4.74 | -0.224 | -2.36 | -0.214 | -5.87 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.159 | 0.448 | 0.728 | 0.371 | 0.564 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.58 | 0.224 | -1.63 | 0.157 | -5.31 |
| Financing Cash Flow Items | -1.56 | -7.13 | -0.349 | -3.55 | -3.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 47.6 | 28.1 | 4.86 | 8.21 | -9.22 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.081 | 20.4 | -9.22 | 3.47 | 5.37 |